mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.7 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.7 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
0.021 |
0.7 |